060280 — CUREXO Share Price
Last trade - 00:00- KR₩317bn
- KR₩292bn
- KR₩75bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 38.94 | ||
| PEG Ratio (f) | 1.62 | ||
| EPS Growth (f) | 31.72% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.14 | ||
| Price to Tang. Book | 3.16 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.08 | ||
| EV to EBITDA | 48.49 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.19% | ||
| Return on Equity | 5.67% | ||
| Operating Margin | 4.18% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 42,794.97 | 64,990.65 | 72,882.22 | 55,531.26 | 74,531.82 | 86,333 | 100,450 | 13.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +153.52 | +19.3 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CUREXO, INC. is a Korea-based company primarily engaged in the manufacturing and sale of medical robots. The Company operates through three business segments. The Medical Robot segment is mainly engaged in the development and sales of orthopedic surgical robots, rehabilitation robots, and other medical devices. The Implant segment is mainly engaged in the development and sales of artificial joint implants. The Trading segment is engaged in the import and sales of food ingredients.
Directors
- Jae Jun Lee CEO (46)
- Hun Sang Cho VPR (58)
- Jin Seok Seo VPR (64)
- Yong Chan Jung MDR (46)
- Yeong Min Jung OTH (50)
- Bong Chu Kim OTH (46)
- Ki Mun In DRC (63)
- Tae Gyu Park DRC (44)
- Dong Su Gwon NID (56)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- February 29th, 1992
- Public Since
- July 3rd, 2002
- No. of Shareholders
- 59,873
- No. of Employees
- 99
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 41,259,790
- Address
- 4F, 577, Gangnam-Daero, Seocho-Gu, SEOUL, 05814
- Web
- http://www.curexo.com/
- Phone
- +82 262028500
- Auditors
- Ernst & Young Han Young
Latest News for 060280
Upcoming Events for 060280
Curexo Inc Annual Shareholders Meeting
Similar to 060280
Boratr
Korea Exchange - KOSDAQ
CJ Freshway
Korea Exchange - KOSDAQ
CosLeaguer Global
Korea Exchange - KOSDAQ
CuroHoldings
Korea Exchange - KOSDAQ
KBio Labs
Korea Exchange - KOSDAQ
FAQ
As of Today at 02:09 UTC, shares in CUREXO are trading at KR₩7,680. This share price information is delayed by 15 minutes.
Shares in CUREXO last closed at KR₩7,680 and the price had moved by -27.7% over the past 365 days. In terms of relative price strength the CUREXO share price has underperformed the FTSE Developed Asia Pacific Index by -47.2% over the past year.
The overall consensus recommendation for CUREXO is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCUREXO does not currently pay a dividend.
CUREXO does not currently pay a dividend.
CUREXO does not currently pay a dividend.
To buy shares in CUREXO you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩7,680, shares in CUREXO had a market capitalisation of KR₩317bn.
Here are the trading details for CUREXO:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 060280
Based on an overall assessment of its quality, value and momentum CUREXO is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in CUREXO is KR₩17,000. That is 121.35% above the last closing price of KR₩7,680.
Analysts covering CUREXO currently have a consensus Earnings Per Share (EPS) forecast of KR₩171 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CUREXO. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -53.99%.
As of the last closing price of KR₩7,680, shares in CUREXO were trading -37.95% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CUREXO PE ratio based on its reported earnings over the past 12 months is 38.94. The shares last closed at KR₩7,680.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
CUREXO's management team is headed by:
- Jae Jun Lee - CEO
- Hun Sang Cho - VPR
- Jin Seok Seo - VPR
- Yong Chan Jung - MDR
- Yeong Min Jung - OTH
- Bong Chu Kim - OTH
- Ki Mun In - DRC
- Tae Gyu Park - DRC
- Dong Su Gwon - NID